行情

ABT

ABT

雅培
NYSE

实时行情|Nasdaq Last Sale

84.40
+0.64
+0.76%
交易中 12:37 11/12 EST
开盘
83.76
昨收
83.76
最高
84.78
最低
83.68
成交量
177.40万
成交额
--
52周最高
88.76
52周最低
65.44
市值
1,492.58亿
市盈率(TTM)
45.63
分时
5日
1月
3月
1年
5年

分析师评级

19位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ABT 新闻

  • Abbott Ireland Financing DAC -- Moody's assigns A3 ratings to Abbott's unsecured euro note offering
  • Moody's.6小时前
  • Investing In Franchisors For Recurring High-Margin Sales At Low CapEx
  • Seeking Alpha - Article.1天前
  • 3 Top Healthcare Stocks to Buy Right Now
  • MotleyFool.com.1天前
  • Abbott Is One Of The Biggest Medical Stocks — Should You Buy ABT Stock Now?
  • Investor's Business Daily.4天前

更多

所属板块

医疗设备、用品及经销
+0.62%
医疗设备和用品
+0.65%

热门股票

名称
价格
涨跌幅

ABT 简况

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.
展开

Webull提供Abbott Laboratories的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。